The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1478-6362
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis ; volume:22 ; number:1 ; day:2 ; month:10 ; year:2020 ; pages:1-10 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (2.10.2020), 1-10, 12.2020

Creator
Wu, Kai-Li
Liang, Qing-Hui
Huang, Bin-Tao
Ding, Na
Li, Bo-Wei
Hao, Jian
Contributor
SpringerLink (Online service)

DOI
10.1186/s13075-020-02321-w
URN
urn:nbn:de:101:1-2020112021080464908458
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Wu, Kai-Li
  • Liang, Qing-Hui
  • Huang, Bin-Tao
  • Ding, Na
  • Li, Bo-Wei
  • Hao, Jian
  • SpringerLink (Online service)

Other Objects (12)

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis

Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis

Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review

Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review

Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis

Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China: Epidemiology, Management, Prognosis, and Outlook

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis

Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis

Related objects